{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "In this prospective, double-blind, randomized controlled trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "In this prospective, double-blind, randomized controlled trial, 64 patients"
      },
      "Participants": {
        "score": 2,
        "evidence": "64 patients requiring IONM during cervical spine surgery"
      },
      "Intervention": {
        "score": 2,
        "evidence": "administered either propofol (Group P) or remimazolam (Group R)"
      },
      "Objective": {
        "score": 1,
        "evidence": "Here, we compared the effects of propofol and remimazolam along with remifentanil on IONM during TIVA."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the between-group difference in the N20 latency changes measured at T1 and preoperatively."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 2,
        "evidence": "double-blind"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "64 patients"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The change in SEP latencies including N20 and P37 at T1 compared with preoperative time was not significantly different between Groups P and R."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 14,
    "max_score": 25
  },
  "model": "gpt-4o"
}